[PHARMA] QoQ Quarter Result on 30-Sep-2019 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -94.82%
YoY- -96.8%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 645,763 819,921 715,683 716,849 601,890 786,108 596,644 5.42%
PBT 14,326 30,880 -238,474 3,885 12,481 30,243 11,940 12.92%
Tax -4,719 -8,465 59,741 -3,509 -3,219 -10,595 -7,370 -25.73%
NP 9,607 22,415 -178,733 376 9,262 19,648 4,570 64.17%
-
NP to SH 9,979 22,399 -178,598 481 9,281 19,617 4,437 71.74%
-
Tax Rate 32.94% 27.41% - 90.32% 25.79% 35.03% 61.73% -
Total Cost 636,156 797,506 894,416 716,473 592,628 766,460 592,074 4.90%
-
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 6,530 15,673 - - 6,514 15,630 5,202 16.38%
Div Payout % 65.45% 69.98% - - 70.19% 79.68% 117.26% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
NOSH 261,705 261,229 261,229 261,229 261,229 260,505 260,505 0.30%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 1.49% 2.73% -24.97% 0.05% 1.54% 2.50% 0.77% -
ROE 2.79% 6.40% -53.06% 0.09% 1.79% 3.71% 0.87% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 247.20 313.87 274.30 274.86 230.98 301.76 229.36 5.12%
EPS 3.82 8.57 -68.45 0.18 3.56 7.53 1.71 70.97%
DPS 2.50 6.00 0.00 0.00 2.50 6.00 2.00 16.05%
NAPS 1.37 1.34 1.29 1.98 1.99 2.03 1.96 -21.25%
Adjusted Per Share Value based on latest NOSH - 261,229
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 44.81 56.89 49.66 49.74 41.76 54.54 41.40 5.42%
EPS 0.69 1.55 -12.39 0.03 0.64 1.36 0.31 70.55%
DPS 0.45 1.09 0.00 0.00 0.45 1.08 0.36 16.05%
NAPS 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 -21.04%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 2.22 1.26 2.06 2.44 2.84 2.27 2.78 -
P/RPS 0.90 0.40 0.75 0.89 1.23 0.75 1.21 -17.92%
P/EPS 58.12 14.69 -3.01 1,322.99 79.74 30.14 162.99 -49.74%
EY 1.72 6.81 -33.23 0.08 1.25 3.32 0.61 99.71%
DY 1.13 4.76 0.00 0.00 0.88 2.64 0.72 35.08%
P/NAPS 1.62 0.94 1.60 1.23 1.43 1.12 1.42 9.19%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 -
Price 4.42 1.88 2.04 2.21 2.66 2.36 2.76 -
P/RPS 1.79 0.60 0.74 0.80 1.15 0.78 1.20 30.58%
P/EPS 115.71 21.93 -2.98 1,198.28 74.69 31.34 161.81 -20.04%
EY 0.86 4.56 -33.55 0.08 1.34 3.19 0.62 24.40%
DY 0.57 3.19 0.00 0.00 0.94 2.54 0.72 -14.43%
P/NAPS 3.23 1.40 1.58 1.12 1.34 1.16 1.41 73.86%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment